Literature DB >> 11305972

Heart failure in blacks: etiologic and epidemiologic differences.

C W Yancy1.   

Abstract

Heart failure in black Americans has become a cardiovascular conundrum of increasing clinical significance. Over 60% of black patients with heart failure have an antecedent history of hypertension as a putative cause of left ventricular (LV) dysfunction, whereas only 30% have coronary artery disease as the suspected cause of LV dysfunction. Once affected with heart failure, the natural history of the disease becomes worrisome: LV dysfunction is more advanced, the severity of the disease is worse, the hospitalization rate is higher, and the mortality rate is at least 30% higher than that of white Americans. When treated in a conventional manner, available data have been inconsistent, and reliable drug efficacy has not been demonstrated. These differences do not appear to be due to socioeconomic factors. It is quite possible that unique pertubations in the neurohormonal environment may explain differences in the natural history of heart failure in blacks and yield new targets of therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11305972     DOI: 10.1007/s11886-001-0022-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  21 in total

1.  Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C.

Authors:  J D Moore; D A Mason; S A Green; J Hsu; S B Liggett
Journal:  Hum Mutat       Date:  1999-09-19       Impact factor: 4.878

Review 2.  The heart in hypertension.

Authors:  E D Frohlich; C Apstein; A V Chobanian; R B Devereux; H P Dustan; V Dzau; F Fauad-Tarazi; M J Horan; M Marcus; B Massie
Journal:  N Engl J Med       Date:  1992-10-01       Impact factor: 91.245

3.  Insertion/deletion polymorphism within a polyadenylate stretch at the human atrial natriuretic peptides (hANP) gene locus.

Authors:  R Ramasawmy; C Y Lu; N Kok-Sun; N Kotea; S Baligadoo; R Krishnamoorthy
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

4.  beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma.

Authors:  T D Weir; N Mallek; A J Sandford; T R Bai; N Awadh; J M Fitzgerald; D Cockcroft; A James; S B Liggett; P D Paré
Journal:  Am J Respir Crit Care Med       Date:  1998-09       Impact factor: 21.405

5.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

Authors: 
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

6.  Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.

Authors:  P M Oliver; J E Fox; R Kim; H A Rockman; H S Kim; R L Reddick; K N Pandey; S L Milgram; O Smithies; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 7.  Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling.

Authors:  M Kirchengast; K Münter
Journal:  Proc Soc Exp Biol Med       Date:  1999-09

Review 8.  Hypertensive heart disease and heart failure.

Authors:  R J Cody
Journal:  Curr Opin Cardiol       Date:  1995-09       Impact factor: 2.161

9.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

10.  Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.

Authors:  M Suthanthiran; B Li; J O Song; R Ding; V K Sharma; J E Schwartz; P August
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  4 in total

1.  Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertension.

Authors:  Aaron M Brody; John M Flack; Brian A Ference; Phillip D Levy
Journal:  Crit Pathw Cardiol       Date:  2014-09

Review 2.  Public Health, Hypertension, and the Emergency Department.

Authors:  Aaron Brody; Alex Janke; Vineet Sharma; Phillip Levy
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

3.  Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study.

Authors:  Ambarish Pandey; Neil Keshvani; Colby Ayers; Adolfo Correa; Mark H Drazner; Alana Lewis; Carlos J Rodriguez; Michael E Hall; Ervin R Fox; Robert J Mentz; Christopher deFilippi; Stephen L Seliger; Christie M Ballantyne; Ian J Neeland; James A de Lemos; Jarett D Berry
Journal:  JAMA Cardiol       Date:  2019-01-01       Impact factor: 14.676

4.  Race and the natural history of chronic heart failure: a propensity-matched study.

Authors:  Giovanni Gambassi; Syed Abbas Agha; Xuemei Sui; Clyde W Yancy; Javed Butler; Grigorios Giamouzis; Thomas E Love; Ali Ahmed
Journal:  J Card Fail       Date:  2008-05-27       Impact factor: 5.712

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.